HIGHLIGHTS
- who: Shakira Yoosuf from the The University of Chicago, United States have published the paper: Pancreatic enzyme supplementation versus placebo for improvement of gastrointestinal symptoms in non-responsive celiac disease: A cross-over randomized controlled trial, in the Journal: (JOURNAL)
- what: The trial was terminated prematurely by the sponsor for administrative reasons. This study attempted to address the knowledge gap concerning the use of PES for NRCD irrespective of the presence of demonstrable PEI, which is a clinically relevant question. With a rigorous Frontiers in Medicine study design, validated measures of GI symptoms and GFD . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.